$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Infertilitetsbehandling og kreftrisiko 원문보기

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række, v.132 no.22, 2012년, pp.2494 - 2499  

Storeng, Ritsa ,  Vangen, Siri ,  Omland, Anne Katerine ,  Oldereid, Nan Birgitte

초록이 없습니다.

참고문헌 (49)

  1. 10.1093/humrep/dem046 Boivin J, Bunting L, Collins JA et al. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007; 22: 1506 - 12. 

  2. Wright VC, Chang J, Jeng G et al. Assisted reproductive technology surveillance-United States, 2005. MMWR Surveill Summ 2008; 57: 1 - 23. 

  3. U.S.Department of Health and Human Services, National Institutes of Health. FactSheet; Menopausal hormone therapy and cancer. www.cancer.gov/cancertopics/factsheet/Risk/menopausal-hormones (10.10.2012). 

  4. 10.1038/cr.2008.52 Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res 2008; 18: 538 - 48. 

  5. Haldorsen T, red. Cancer in Norway 2009. Special issue: Cancer screening in Norway. Oslo: Kreftregisteret, 2011. 

  6. 10.1093/aje/kwn318 Calderon-Margalit R, Friedlander Y, Yanetz R et al. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 2009; 169: 365 - 75. 

  7. 10.1016/S0015-0282(01)02986-7 Dor J, Lerner-Geva L, Rabinovici J et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002; 77: 324 - 7. 

  8. 10.1093/humrep/17.8.2209 Doyle P, Maconochie N, Beral V et al. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002; 17: 2209 - 13. 

  9. 10.1093/humrep/deh422 Gauthier E, Paoletti X, Clavel-Chapelon F; E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004; 19: 2216 - 21. 

  10. 10.1046/j.1525-1438.2003.13041.x Lerner-Geva L, Geva E, Lessing JB et al. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 2003; 13: 23 - 7. 

  11. 10.3109/09513590.2012.671391 Liat LG, Jaron R, Liraz O et al. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol 2012; 28: 809 - 14. 

  12. 10.1006/gyno.1996.0002 Rossing MA, Daling JR, Weiss NS et al. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol 1996; 60: 3 - 7. 

  13. 10.1093/humrep/des031 Yli-Kuha AN, Gissler M, Klemetti R et al. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 2012; 27: 1149 - 55. 

  14. 10.1093/humrep/deq307 Kallen B, Finnstrom O, Lindam A et al. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod 2011; 26: 253 - 8. 

  15. 10.1001/archinte.166.22.2484 Terry KL, Willett WC, Rich-Edwards JW et al. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 2006; 166: 2484 - 9. 

  16. 10.1093/humrep/deh371 Brinton LA, Scoccia B, Moghissi KS et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004; 19: 2005 - 13. 

  17. 10.1158/1055-9965.EPI-07-0075 Jensen A, Sharif H, Svare EI et al. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1400 - 7. 

  18. 10.1111/j.1524-4741.2008.00641.x Katz D, Paltiel O, Peretz T et al. Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study. Breast J 2008; 14: 517 - 22. 

  19. 10.1007/s10549-006-9238-4 Lerner-Geva L, Keinan-Boker L, Blumstein T et al. Infertility, ovulation induction treatments and the incidence of breast cancer-a historical prospective cohort of Israeli women. Breast Cancer Res Treat 2006; 100: 201 - 12. 

  20. 10.1016/j.ajog.2008.08.066 Orgeas CC, Sanner K, Hall P et al. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. Am J Obstet Gynecol 2009; 200: 72.e1 - 7. 

  21. 10.1038/sj.bjc.6605086 dos Santos Silva I, Wark PA, McCormack VA et al. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 2009; 100: 1824 - 31. 

  22. 22 Venn A, Watson L, Bruinsma F et al 354 1586 - 90 Lancet 

  23. 10.1007/s10549-010-1140-4 Zreik TG, Mazloom A, Chen Y et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 2010; 124: 13 - 26. 

  24. 10.1016/j.fertnstert.2004.02.109 Brinton LA, Lamb EJ, Moghissi KS et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004; 82: 405 - 14. 

  25. 10.1080/09513590701350341 Cusido M, Fabregas R, Pere BS et al. Ovulation induction treatment and risk of borderline ovarian tumors. Gynecol Endocrinol 2007; 23: 373 - 6. 

  26. 26 Jensen A, Sharif H, Frederiksen K et al 338 b249 BMJ 

  27. 10.1016/S0015-0282(98)00337-9 Mosgaard BJ, Lidegaard O, Kjaer SK et al. Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 1998; 70: 1049 - 55. 

  28. 10.1093/aje/kwh315 Rossing MA, Tang MT, Flagg EW et al. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol 2004; 160: 1070 - 8. 

  29. 10.1093/oxfordjournals.humrep.a138771 Franceschi S, La Vecchia C, Negri E et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994; 9: 1673 - 5. 

  30. 10.1093/humrep/der322 van Leeuwen FE, Klip H, Mooij TM et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 2011; 26: 3456 - 65. 

  31. 10.1016/j.fertnstert.2008.01.073 Sanner K, Conner P, Bergfeldt K et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 2009; 91: 1152 - 8. 

  32. 10.1056/NEJM199409223311204 Rossing MA, Daling JR, Weiss NS et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771 - 6. 

  33. 10.1016/S0015-0282(16)58020-0 Shushan A, Paltiel O, Iscovich J et al. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13 - 8. 

  34. 10.1093/aje/kwi084 Althuis MD, Moghissi KS, Westhoff CL et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 2005; 161: 607 - 15. 

  35. 10.1093/aje/kwp290 Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol 2009; 170: 1408 - 14. 

  36. 10.1016/j.ajog.2005.01.091 Althuis MD, Scoccia B, Lamb EJ et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 2005; 193: 668 - 74. 

  37. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update 2012; e-publisert 19.5.2012. 

  38. 10.1002/ijc.2910460204 Tretli S, Magnus K. Height and weight in relation to uterine corpus cancer morbidity and mortality. A follow-up study of 570,000 women in Norway. Int J Cancer 1990; 46: 165 - 72. 

  39. 10.1016/S1470-2045(11)70404-1 Pearce CL, Templeman C, Rossing MA et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385 - 94. 

  40. 40 Giudice LC, Kao LC 364 1789 - 99 Lancet 

  41. 10.1093/humupd/7.6.522 Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001; 7: 522 - 5. 

  42. 10.1200/JCO.2008.18.1107 Levanon K, Crum C, Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 2008; 26: 5284 - 93. 

  43. 10.1016/j.ygyno.2011.10.017 Manchanda R, Drapkin R, Jacobs I et al. The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecol Oncol 2012; 124: 185 - 91. 

  44. 10.1016/j.fertnstert.2004.09.016 Brinton LA, Moghissi KS, Scoccia B et al. Ovulation induction and cancer risk. Fertil Steril 2005; 83: 261 - 74. 

  45. 45 Fathalla MF 2 163 Lancet 

  46. 46 Adami HO, Hsieh CC, Lambe M et al 344 1250 - 4 Lancet 

  47. 47 Hankinson SE, Colditz GA, Hunter DJ et al 76 284 - 90 Cancer 

  48. 10.1016/S0015-0282(97)81431-8 Mosgaard BJ, Lidegaard O, Kjaer SK et al. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997; 67: 1005 - 12. 

  49. 10.1093/aje/kwn094 Jensen A, Sharif H, Olsen JH et al. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J Epidemiol 2008; 168: 49 - 57. 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로